top of page
Gradient.jpg
ABOUT

Polybiomics is revolutionizing the analysis of live cells.

Our innovative technology and proprietary process enables simultaneous measurements of multiple cellular features from the same sample in real-time. Our analytics connects multiple data types to create new knowledge and derive deep actionable insights, currently unattainable. This accelerates discovery and product development in pharma and clinic, and positions Polybiomics at the forefront of a multi-billion dollar market.
SOLUTIONS

THE POLYBIOMICS SOLUTION

Polybiomics is offering a disruptive live cell analysis platform for drug discovery and development, enabling the use of a single-instrument to generate interlinked datasets through multimodal testing of a single sample under constant conditions. Our solution uses AI to create actionable insights and predict outcomes, saving sims, costs, and protecting sample integrity. 
Integrated System
and Consumable
PolyProduct_01-wCloud_R2.jpg
PolyData™
and Analytics

 
Actionable
Intelligence
Data copy.jpg
INtel.jpg

OUR TEAM

LEADERSHIP

Mandana Veiseh, PhD

Founder, President, CSTO

Bahram Bahrami, PhD

Co-founder, CEO

TEAM

David Stumbo, PhD

Shahab S. Bahaei, PhD

Ava Aslanpour, BE

Kayla Solomon, BS

Bob Smith-McCollum, MBA

Navya Mangipudi

David Duhl, PhD

SCIENTIFIC ADVISORY

Mina J Bissell, PhD

National Academy Member

Kurt Petersen, PhD

National Academy Member

Ron W Davis, PhD

National Academy Member

Rick Horwitz, PhD

 

 

ADVISORS

Darren Cooke, JD

Natalie Wisniewski, PhD

Pirooz Parvarandeh, MS

Jeff Hartlin, JD

Sandeep Sheriff, CPA

 

TEAM
CONTACT

CONTACT US

bottom of page